- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Acquisition of 25.1 % of the shares - Low six-figure purchase price consisting of cash and shares - sarastro produces applications for medically compatible surfaces, the prevention of biofilm formation and for antimicrobial surfaces - sarastro is profitable, has high growth potential and is specialised in medical technology applications - Option for majority holding secured - Development of joint products at an advanced stage.
Nanogate (ISIN DE000A0JKHC9), a leading international nanotechnology enabler, is strengthening its sales potential through its equity holding in sarastro GmbH and is expanding its technical expertise to include bio-compatible solutions. The nanotechnology company sarastro specialises in manufacturing antimicrobial and medically compatible surfaces. Nanogate and sarastro plan to enhance materials, surfaces and products for various applications with new biological properties and in doing so offer powerful solutions for a dynamically growing market. For 2009 sarastro anticipates sales in the high six-figure euros and was able to reach a sustainable level of profitability in the current financial year.
Through the transaction Nanogate AG is initially acquiring 25.1 % of the shares from the founders of sarastro GmbH. The purchase price is a low six-figure euro amount and is made up of cash and shares. In addition, Nanogate will soon implement a small capital increase from authorised capital.
Majority option secured
In a notarised contract, Nanogate AG has already secured the increase of its stake in the company to 51%. The option can be exercised in the coming years.
Broad range of products
sarastro technology is already used in hearing instruments from Siemens and from a well-known Swiss manufacturer, in filtration plants for drinking water purification, and in PVC air and water hoses. Furthermore, the company produces disinfectants and other liquids using patented technology to create a particularly long-lasting disinfecting and antimicrobial effect. These are used by Wincor- Nixdorf, for example, in the maintenance of ATMs. Demand for these products is currently experiencing lively growth. sarastro's applications are based on the same chemical nanotechnology that Nanogate uses. The company is certified in accordance with the German Medical Devices Act. The first joint products in the Buildings/Interiors, Sport/Leisure and Automotive/Mechanical Engineering divisions are already at an advanced development stage and should come on the market next year.
According to Ralf Zastrau, CEO of Nanogate AG, "sarastro is an ideal partner for Nanogate in terms of strategy, technology and products. The demand for antimicrobially enhanced or bio-compatible surfaces and materials is growing rapidly. Consumers and industry increasingly require powerful solutions that protect against bacteria and germs. Nanogate will benefit significantly from the new equity holding. We expect it to make a positive contribution to earnings as early as 2010."
Rainer Hanselmann, Managing Director of sarastro GmbH comments: "This partnership will enable Nanogate to increase its level of expertise and will also accelerate product development and market introduction processes at sarastro. Our skill in biological-medical applications with many well-known partners combined with Nanogate's considerable industry expertise and broad customer base create an excellent foundation for numerous new applications and product solutions. sarastro and Nanogate will profit equally from this close collaboration."
This publication constitutes neither an offer to sell nor an invitation to buy securities. The shares in Nanogate AG (the "Shares") may not be offered or sold in the United States or to or for the account or benefit of "U.S. persons" (as such term is defined in Regulation S under the U.S. Securities Act of 1933, as amended (the "Securities Act")). No offer or sale of transferable securities is being made to the public outside Germany.
Nanogate is a leading international enabler in the nanotechnology growth market and so opens the gate to this technology for its customers. The firm, which is based in Göttelborn (Saarland), enables the programming and integration of additional properties such as non-stick, anti-bacterial, anti-corrosive and ultra-low friction. Nanogate thereby gains a competitive edge for its customers by product refinement using chemical nanotechnology.
Nanogate covers a wide range of industries, functions and substrates already on the basis of technology platforms. The company thus provides a decisive interface for the commercialisation of chemical nanotechnology, bridges the gap between raw materials and their industrial conversion into products and concentrates as an enabler on one of the most attractive segments in the industry. As a partner in innovation, Nanogate provides many services along the value chain – from development and production of innovative nanocomposites and nanostructured materials to powerful support for innovation and product integration.
The Nanogate Group currently has 84 employees in all (as of September 2009) and since commencing operations in 1999 has been a pioneer in nanotechnology. Nanogate is a high-growth company and has operated profitably since financial year 2004. In financial year 2007 it boosted consolidated sales by almost 17 % to around EUR 12.2 million. The earnings before taxes (EBT, according to IFRS) amounted to around EUR 1.1 million. The company has first-class customer references (e.g. ABB, BSH Bosch-Siemens Haushaltsgeräte, Kärcher and Koenig & Bauer AG) and many years’ experience of different industries and applications. It has also entered into strategic cooperation with international companies such as Dow Corning. The Group’s consolidation entity includes Nanogate Advanced Materials GmbH, which specialises in complex applications like high-performance optics, FNP GmbH in the area of sport/leisure and a majority shareholding in Holmenkol AG.
For more information, please click here
Christian Dose (financial press and investors)
Cortent Kommunikation AG
Tel. +49 (0)69 5770 300-0
Karen Kumposcht (business and trade press)
MPW FINANCE Public & Investor Relations GmbH
Tel. +49 (0)69 9592 90-12
Zum Schacht 3
Copyright © NanogateIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Harris & Harris Group Sponsors NYC American Heart Association's Health Sciences Innovation Investment Forum: Co-founder of Harris & Harris Group Portfolio Company TARA Biosystems to Speak About the Value of Tissue Engineering Technology April 21st, 2015
Long Island Capital Alliance Announces Participants for Brookhaven National Laboratory Technology Transfer Capital Forum on May 8: Keynote Speaker Dr. Doon Gibbs, Director of Brookhaven National Laboratory April 16th, 2015
Graphenea embarks on a new era April 16th, 2015
Quantum model reveals surface structure of water: National Physical Laboratory, IBM and Edinburgh University have used a new quantum model to reveal the molecular structure of water's liquid surface April 20th, 2015
Dais Analytic Corporation Appoints Eliza Wang to Board of Directors: Company's Newest Director Brings Expertise in Commercial and Legal Matters Both in the United States and China; Joins on the Heels of Successful Business Development Trade Mission to China April 18th, 2015
Rafts on the cell membrane: Researchers from TU Wien (Vienna) shed light on a big secret of cell membranes: The 'lipid rafts', which have been believed to move within the cell membrane, do not really exist April 21st, 2015